Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
RabiVax-S
- Development stage
- Preclinical
- Lead developer
- Serum Institute of India
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
RabiVax-S is a thermostable, single-dose formulation of the Serum Institute of India's (SII) inactivated rabies vaccine, Rabivax-S. Developed using VitriVax's proprietary ALTA® (Atomic Layering for Therapeutic Assistance) platform, the vaccine is engineered to eliminate the need for cold-chain logistics and to provide a full course of immunization in a single injection. The ALTA® technology involves a spray-drying process that encapsulates the vaccine antigens in a protective sugar-glass matrix, which can be tailored for immediate or sustained release to mimic a prime-boost regimen. This candidate is intended for both pre-exposure and post-exposure prophylaxis of rabies, particularly in low- and middle-income countries where cold-chain infrastructure is limited. It is currently in preclinical development with support from the Coalition for Epidemic Preparedness Innovations (CEPI).
- Brand names
- Rabivax-S
- Other names
- Rabivax-S
Beyond the preview
Go deeper on RabiVax-S.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RabiVax-S.